Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G J Blauw

Showing results (1-10 of 72) with videos related to

Pageof 8
Sort By:
Lancet (London, England)|January 7, 1995
Asthma deaths in New Zealand: whodunnit?G J Blauw, R G Westendorp
Lancet (London, England)|April 15, 1995
End of New Zealand asthma epidemicR G Westendorp, G J Blauw
Lancet (London, England)|March 27, 2001
Dementia and statins. PROSPER study groupG J Blauw, J Shepherd, M B Murphy, et al.
Lancet (London, England)|July 22, 1998
Statins for prevention of strokeG J Blauw, A M Lagaay, R G Westendorp
American Journal of Hypertension|April 1, 1991
Arterial and venous effects of atrial natriuretic peptide in the human forearmC J Doorenbos, G J Blauw, P van Brummelen
Clinical Physiology and Biochemistry|January 1, 1990
Pathophysiological and pharmacotherapeutic aspects of serotonin and serotonergic drugsP A van Zwieten, G J Blauw, P van Brummelen
Pharmacology & Toxicology|June 1, 1992
Serotonergic receptors and drugs in hypertensionP A van Zwieten, G J Blauw, P van Brummelen
Cardiovascular Drugs and Therapy|December 1, 1990
The role of serotonin in cardiovascular diseases and their treatmentP A van Zwieten, G J Blauw, P van Brummelen
Clinical Physiology (Oxford, England)|September 29, 2001
Forearm blood flow measurements using computerized R-wave triggered strain-gauge venous occlusion plethysmography: unilateral vs. bilateral measurementsA M Kamper, A J de Craen, G J Blauw
Life Sciences|January 1, 1988
Serotonin induced vasodilatation in the human forearm is antagonized by the selective 5-HT3 receptor antagonist ICS 205-930G J Blauw, P van Brummelen, P A van Zwieten
Pageof 8

Showing results (1-10 of 72) with videos related to

Sort By:
Pageof 8
Lancet (London, England)|January 7, 1995
Asthma deaths in New Zealand: whodunnit?G J Blauw, R G Westendorp
Lancet (London, England)|April 15, 1995
End of New Zealand asthma epidemicR G Westendorp, G J Blauw
Lancet (London, England)|March 27, 2001
Dementia and statins. PROSPER study groupG J Blauw, J Shepherd, M B Murphy, et al.
Lancet (London, England)|July 22, 1998
Statins for prevention of strokeG J Blauw, A M Lagaay, R G Westendorp
American Journal of Hypertension|April 1, 1991
Arterial and venous effects of atrial natriuretic peptide in the human forearmC J Doorenbos, G J Blauw, P van Brummelen
Clinical Physiology and Biochemistry|January 1, 1990
Pathophysiological and pharmacotherapeutic aspects of serotonin and serotonergic drugsP A van Zwieten, G J Blauw, P van Brummelen
Pharmacology & Toxicology|June 1, 1992
Serotonergic receptors and drugs in hypertensionP A van Zwieten, G J Blauw, P van Brummelen
Cardiovascular Drugs and Therapy|December 1, 1990
The role of serotonin in cardiovascular diseases and their treatmentP A van Zwieten, G J Blauw, P van Brummelen
Clinical Physiology (Oxford, England)|September 29, 2001
Forearm blood flow measurements using computerized R-wave triggered strain-gauge venous occlusion plethysmography: unilateral vs. bilateral measurementsA M Kamper, A J de Craen, G J Blauw
Life Sciences|January 1, 1988
Serotonin induced vasodilatation in the human forearm is antagonized by the selective 5-HT3 receptor antagonist ICS 205-930G J Blauw, P van Brummelen, P A van Zwieten
Pageof 8